{"doi":"10.1523/jneurosci.4357-09.2009","title":"Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine)","abstract":"<jats:p>Mutations in the<jats:italic>leucine-rich repeat kinase 2</jats:italic>(<jats:italic>LRRK2</jats:italic>) gene are the most common known cause of Parkinson's disease (PD). Whether loss of LRRK2 function accounts for neurodegeneration of dopamine neurons in PD is not known, nor is it known whether LRRK2 kinase activity modulates the susceptibility of dopamine (DA) neurons to the selective dopaminergic toxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). To better understand the role of LRRK2 in DA neuronal survival and its role in the susceptibility of DA neurons to MPTP, we generated LRRK2 knock-out (KO) mice lacking the kinase domain of LRRK2. Here, we show that LRRK2 KO mice are viable and have no major abnormalities and live to adulthood. The dopaminergic system is normal in LRRK2 KO mice as assessed via HPLC for DA and its metabolites and via stereologic assessment of DA neuron number in young and aged mice. Importantly, there is no significant difference in the susceptibility of LRRK2 KO and wild-type mice to MPTP. These results suggest that LRRK2 plays little if any role in the development and survival of DA neurons under physiologic conditions. Thus, PD due to LRRK2 mutations are likely not due to a loss of function. Moreover, LRRK2 is not required for the susceptibility of DA neurons to MPTP.</jats:p>","journal":"The Journal of Neuroscience","year":2009,"id":623085,"datarank":0.7324202883879557,"base_score":4.882801922586371,"endowment":4.882801922586371,"self_citation_contribution":0.7324202883879557,"citation_network_contribution":0.0,"self_endowment_contribution":0.7324202883879557,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":131,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1610219,"name":"Rebeca Mejias","orcid":null,"position":1,"is_corresponding":false},{"id":353429,"name":"Masayuki Sasaki","orcid":"0000-0001-8518-2912","position":2,"is_corresponding":false},{"id":1153074,"name":"Xiaojie Li","orcid":"0000-0002-9064-0882","position":3,"is_corresponding":false},{"id":320858,"name":"Brian M. Lin","orcid":"0000-0002-8991-8082","position":4,"is_corresponding":false},{"id":322418,"name":"Saskia Biskup","orcid":"0000-0002-1573-861X","position":5,"is_corresponding":false},{"id":440096,"name":"Li Zhang","orcid":"0000-0003-0006-4066","position":6,"is_corresponding":false},{"id":1593763,"name":"Rebecca Banerjee","orcid":null,"position":7,"is_corresponding":false},{"id":644388,"name":"Bobby Thomas","orcid":"0000-0001-9244-9726","position":8,"is_corresponding":false},{"id":1610222,"name":"Lichuan Yang","orcid":null,"position":9,"is_corresponding":false},{"id":1072652,"name":"Guosheng Liu","orcid":"0000-0001-7899-6125","position":10,"is_corresponding":false},{"id":107438,"name":"M. Flint Beal","orcid":null,"position":11,"is_corresponding":false},{"id":680844,"name":"David L. Huso","orcid":null,"position":12,"is_corresponding":false},{"id":68267,"name":"Ted M. Dawson","orcid":"0000-0002-6459-0893","position":13,"is_corresponding":false},{"id":68266,"name":"Valina L. Dawson","orcid":"0000-0002-2915-3970","position":14,"is_corresponding":false},{"id":1610218,"name":"Eva Andres-Mateos","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine)","abstract":"<jats:p>Mutations in the<jats:italic>leucine-rich repeat kinase 2</jats:italic>(<jats:italic>LRRK2</jats:italic>) gene are the most common known cause of Parkinson's disease (PD). Whether loss of LRRK2 function accounts for neurodegeneration of dopamine neurons in PD is not known, nor is it known whether LRRK2 kinase activity modulates the susceptibility of dopamine (DA) neurons to the selective dopaminergic toxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). To better understand the role of LRRK2 in DA neuronal survival and its role in the susceptibility of DA neurons to MPTP, we generated LRRK2 knock-out (KO) mice lacking the kinase domain of LRRK2. Here, we show that LRRK2 KO mice are viable and have no major abnormalities and live to adulthood. The dopaminergic system is normal in LRRK2 KO mice as assessed via HPLC for DA and its metabolites and via stereologic assessment of DA neuron number in young and aged mice. Importantly, there is no significant difference in the susceptibility of LRRK2 KO and wild-type mice to MPTP. These results suggest that LRRK2 plays little if any role in the development and survival of DA neurons under physiologic conditions. Thus, PD due to LRRK2 mutations are likely not due to a loss of function. Moreover, LRRK2 is not required for the susceptibility of DA neurons to MPTP.</jats:p>","is_dataset_classified":null,"base_score":4.882801922586371,"endowment":4.882801922586371,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20016100","pmcid":"PMC2846613","openalex_id":"https://openalex.org/W2027254060","authors":[],"funders":[{"funder_name":"NINDS NIH HHS","grant_id":"NS054207","title":null},{"funder_name":"NINDS NIH HHS","grant_id":"P50 NS38377","title":null},{"funder_name":"NINDS NIH HHS","grant_id":"R21 NS054207","title":null},{"funder_name":"NINDS NIH HHS","grant_id":"NS060885","title":null},{"funder_name":"NINDS NIH HHS","grant_id":"P50 NS038377","title":null},{"funder_name":"NINDS NIH HHS","grant_id":"R01 NS060885","title":null}],"total_grants":6,"fwci":9.4055,"citation_percentile":0.98304782,"influential_citations":0,"citation_trend":[{"year":2012,"count":14},{"year":2013,"count":14},{"year":2014,"count":14},{"year":2015,"count":5},{"year":2016,"count":7},{"year":2017,"count":4},{"year":2018,"count":9},{"year":2019,"count":3},{"year":2020,"count":5},{"year":2021,"count":6},{"year":2022,"count":7},{"year":2023,"count":2},{"year":2025,"count":3},{"year":2026,"count":2}],"oa_status":"bronze","license":"https://creativecommons.org/licenses/by-nc-sa/4.0/","oa_locations":[{"url":"https://www.jneurosci.org/content/jneuro/29/50/15846.full.pdf","host_type":"journal"},{"url":"https://www.jneurosci.org/content/jneuro/29/50/15846.full.pdf","host_type":"publisher"},{"url":"https://syndication.highwire.org/content/doi/10.1523/JNEUROSCI.4357-09.2009","host_type":"publisher"},{"url":"https://doi.org/10.1523/jneurosci.4357-09.2009","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/20016100","host_type":"repository"},{"url":"https://doi.org/10.1523/JNEUROSCI.4357-09.2009","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2846613","host_type":"repository"}],"fields_of_study":["Parkinson's Disease Mechanisms and Treatments","Neurological diseases and metabolism"],"mesh_terms":["Leucine-Rich Repeat Serine-Threonine Protein Kinase-2","Animals","Female","Mice, Inbred C57BL","Neurons","1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","Protein Serine-Threonine Kinases","Mice, Knockout","MPTP Poisoning","Mice"],"keywords":["MPTP","LRRK2","Dopaminergic","Neurodegeneration","Parkinson's disease","Dopamine","Kinase","Tyrosine hydroxylase","Neuroscience","Biology","Dopamine transporter","Pharmacology","Endocrinology","Internal medicine","Chemistry","Cell biology","Medicine","Disease"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T22:20:26.160251Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}